Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib

Part of paid clinical trials in Boca Raton, Florida.

Sponsor
AstraZeneca
Study ID
NCT04421963
Phase
PHASE3
Status
Active Not Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 99 Years
Healthy Volunteers
Not accepted

Interventions

  • Olaparib — DRUG
    300 mg olaparib (2×150 mg tablets) twice daily

Study Details

The rationale of the ROSY-O study is to continue to provide study treatment for patients who have participated in a parent study with olaparib and who are continuing to derive clinical benefit from treatment at the end of such studies, as judged by the Investigator.

Key Dates

Start date
Aug 4, 2020
Status verified
Apr 2026
Primary completion
Apr 6, 2027
Completion
Apr 6, 2027

Study Design

Enrollment
185 participants (actual)
Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT

Arms

  • Experimental: Olaparib
    Treatment

Primary Outcome Measure

Safety follow up [ Time Frame: Baseline up to approximately 10 years ]

Locations (14)

FacilityCityStateZIPSite coordinators
Research SiteBoca RatonFlorida33486-
Research SiteTowsonMaryland21204-
Research SiteDetroitMichigan48201-
Research SiteMinneapolisMinnesota55407-
Research SiteBasking RidgeNew Jersey07920-
Research SiteHackensackNew Jersey07601-
Research SiteNew YorkNew York10032-
Research SiteThe BronxNew York10461-
Research SitePhiladelphiaPennsylvania19104-
Research SitePittsburghPennsylvania15224-
Research SiteWillow GrovePennsylvania19090-
Research SiteProvidenceRhode Island02905-
Research SiteGermantownTennessee38138-
Research SiteHoustonTexas77030-

Find similar trials in Boca Raton, FL

By condition
Breast cancerOvarian cancer
By specialty
OncologyBreast oncologyWomen's healthGynecologic oncology
By research site
Research Site· Boca Raton, FLResearch Site· Towson, MDResearch Site· Detroit, MIResearch Site· Minneapolis, MNResearch Site· Basking Ridge, NJResearch Site· Hackensack, NJ

Related Studies